KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Invested Capital (2019 - 2025)

GoodRx Holdings' Invested Capital history spans 7 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 8.64% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 8.64%, while the annual FY2025 figure was $1.1 billion, 8.64% down from the prior year.
  • Invested Capital for Q4 2025 was $1.1 billion at GoodRx Holdings, up from $1.1 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.6 billion in Q2 2023 and bottomed at $756.1 million in Q1 2021.
  • The 5-year median for Invested Capital is $1.1 billion (2025), against an average of $1.1 billion.
  • The largest annual shift saw Invested Capital skyrocketed 180.98% in 2021 before it dropped 22.72% in 2024.
  • A 5-year view of Invested Capital shows it stood at $838.7 million in 2021, then soared by 75.7% to $1.5 billion in 2022, then dropped by 3.75% to $1.4 billion in 2023, then fell by 14.25% to $1.2 billion in 2024, then fell by 8.64% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Invested Capital are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).